An official website of the State of Georgia.
How you know
The .gov means it’s official.
Local, state, and federal government websites often end in .gov. State of Georgia government websites and email systems use “georgia.gov” or “ga.gov” at the end of the address. Before sharing sensitive or personal information, make sure you’re on an official state website.
Still not sure?
Call 1-800-GEORGIA to verify that a website is an official website of the State of Georgia.
Centering all provider information to better serve Georgians!
What You Need to Know
The COVID-19 vaccine management system referred to as VMS is available to all pandemic providers across Georgia. VMS is used for COVID vaccine ordering, inventory management, and dose administration. The system provides an efficient and effective method to replace the previous COVID vaccine allocation process.
Call the Georgia Immunization Program at 404-657-3158 or email [email protected] if you need assistance accessing or navigating VMS.
VMS Overview Training - this is a training requirement of all new pandemic providers. Please click here to access the module.
VMS Functionality Training - this training goes in depth to the different actions providers will need to complete in VMS. Please click here to access the module.
to access and download the VMS Provider user guide.
to access and download the VMS Reporting user guide.
“Why isn’t my inventory quantity accurate?”
COVID vaccine inventory should be managed in VMS. To perform inventory deductions (-), please access the Inventory Disposal tile in VMS. If you wish to increase the inventory shown on hand (+), this will be done within the Inventory Addition tile in VMS.
Vaccination providers are required by the Food and Drug Administration (FDA) to report vaccination administration errors, serious adverse events, cases of Multisystem Inflammatory Syndrome, and cases of COVID-19 that result in hospitalization or death following COVID-19 vaccination under Emergency Use Authorization (EUA). Reporting is encouraged for any other clinically significant adverse event even if it is uncertain whether the vaccine caused the event.
Find more information on how to submit a report to the Vaccine Adverse Event Reporting System (VAERS) here or call 1-800-822-7967.
Click here to access the VMS User Guide and instructions for inventory disposal (wastage).
Vaccine orders must be submitted through the Vaccine Management System (VMS) no later than 5:00 P.M. on Tuesdays to be considered for vaccine order delivery each week. Providers may reach send an e-mail to [email protected] or call (404) 657-3158 for questions about vaccine orders or access to the VMS system.
Currently, all vaccine requests are being fulfilled through direct shipments from Pfizer or McKesson or provider-to-provider transfers facilitated by your assigned Immunization Regional Consultant (IRC). Providers with excess vaccines may contact their assigned IRC so these doses can be considered for a future transfer.
Providers will be contacted directly by their assigned IRC to confirm vaccine requests and schedule delivery dates and times.
To minimize the number expired doses, we encourage providers to:
How to handle expired or expiring COVID vaccine supply:
If expired vaccine is inadvertently administered, it is considered a vaccine administration error and requires remediation including a VAERS report, contacting the recipient to inform them of the error, and may or may not require revaccination based on the manufacturer’s guidance. Guidance on vaccine administration errors can be found in Appendix A of the Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States.
Providers who receive Pfizer vaccines should turn off the temperature monitoring device in preparation for return of the shipper to the manufacturer. More information with accompanying photos is available below.
Vaccine storage unit temperatures must be monitored regularly and recorded at the start of each workday. Always record minimum/maximum temperatures, date, time, name of person checking/recording temperature, and actions taken if a temperature excursion occurred. Temperature records must be kept for a minimum of three years or longer if required by your practice or organization.
Providers should not contact Pfizer or Moderna to cancel a vaccine request. If a provider is not able to store a vaccine delivery, they should immediately notify the Georgia Immunization Program by calling 404 657-3158. Public health staff will work to locate a facility where the vaccine can be transferred. The facility that initially requested the vaccine should accept the shipment. Do not open the shipping container. The vaccine should be kept in a secure location until it can be picked up and moved to another location.
The Public Readiness and Emergency Preparedness Act (PREP Act) [LS1] provides immunity for “covered persons” from liability against any claim of loss “caused by, arising out of, relating to, or resulting from” the distribution, administration, or use of COVID-19 vaccines approved by FDA under an EUA or BLA. The only exception to immunity is for claims involving “willful misconduct” as defined in the PREP Act. Detailed information related to legal immunity can be found here and here. If you are concerned about potential liability, we recommend speaking with your attorney directly.
The CDC has provided guidance regarding providers asking individuals for a cash payment for the administration of COVID-19 vaccine. Per CDC it is not allowable to request a payment from the client receiving a COVID-19 vaccine. More information can be found here.
All organizations and providers participating in the CDC COVID-19 Vaccination Program:
For additional information on filing claims for reimbursement of COVID-19 vaccine administration fees, go to:
The current ACIP Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States can be found here.
(866) 483-2958 or email [email protected]
(404) 657-3158 or email [email protected]
Healthcare personnel can use this CDC tool to receive personalized health check-ins after they receive a COVID-19 vaccine, and should encourage all COVID-19 vaccine recipients to participate. V-safe also provides second vaccine dose reminders if needed, and telephone follow-up to anyone who reports medically significant adverse events.
The Georgia Department of Public Health is partnering with the Georgia Poison Center and PunchAlert to provide you with the latest alerts, information, and recommendations from Public Health. PunchAlert is free and allows you to receive instant updates regarding COVID-19. Text COVIDGAHCP to 77297 for provider updates and COVIDGAGEN to 77297 for general updates.
Weekly COVID vaccine inventory reporting is required by the CDC. Additionally, the CDC is directing the public to use VaccineFinder, a searchable database, to find locations offering COVID-19 vaccine. VaccineFinder allows providers to list their on-hand vaccine inventory, vaccination locations, contact and appointment information. Providers will be responsible for registering for VaccineFinder and uploading inventory and managing the publicly displayed information weekly, on Fridays. For more information about VaccineFinder and the onboarding process, please review additional resources available at: https://vaccinefinder.org/covid-provider-resources.
Conversation Guide: COVID-19 Vaccines and Pregnancy - Learn more
Fact Sheet for Patients: Women and COVID-19 Vaccines -
COVID-19 Vaccines for People Considering Pregnancy - Learn more
Guidance on COVID-19 Vaccines for Children & Teens - Learn more
Resources to Promote the COVID-19 Vaccine for Children & Teens - Learn more
How to Talk with Parents and Caregivers about COVID-19 Vaccination - Learn more
COVID-19 Vaccine FAQs for Healthcare Professionals - Learn more
Myths and Facts about COVID-19 Vaccines - Learn more
The CDC's webpage for COVID-19 Vaccine Training and Education for healthcare professionals provides information on COVID-19 vaccine-related training required by professional qualification. Some training modules also allow you to claim Continuing Medical Education (CME) credits. Click here to launch the CDC's COVID-19 Vaccine Training Modules.
The CDC's Clinician Outreach and Communication Activity (COCA) Calls/Webinars feature subject matter experts who will share the most up-to-date information and guidance on key emergency preparedness and response topics. Click here to learn more.
Click here to access the American Academy of Family Physicians' (AAFP) Pandemic Self-Study Package: COVID-19.
Please fill out this survey if you want printed materials with information on how to schedule a COVID-19 vaccination appointment to distribute to patients, and we will send these materials to you.
To view past provider webinars, please visit the DPH Provider Webinars YouTube Playlist.
Share informative videos of healthcare professionals answering common COVID-19 vaccine-related questions and myths on your social media or with patients to inform them about the COVID-19 vaccine. View the DPH "Ask an Expert" Video Series YouTube Playlist.
IAC recently created its Ask the Experts: COVID-19 web page to answer questions about the administration of mRNA COVID-19 vaccines authorized for emergency use by the FDA and recommended by CDC’s Advisory Committee on Immunization Practices. This Ask the Experts web page also provides links to CDC web pages for guidance. The Ask the Experts: COVID-19 web page will grow with more Q&As as additional information becomes available and whenever new vaccines are authorized for use.
There is no data on the impact of the COVID-19 mRNA vaccines on either the tuberculin skin test (TST) (administered by intradermal placement of 0.1 cc of purified protein derivative) or the interferon gamma release assay (IGRA). There is no immunologic reason to believe that a TST or blood draw for IGRA will impact the effectiveness of COVID-19 mRNA vaccines. Please refer to this ‘COVID mRNA vaccines, TST, and IGRA’ letter for additional information.
CDC created new, web-on-demand, self-paced COVID-19 Vaccine Training Modules for Healthcare Professionals who will be administering Moderna and Pfizer BioNTech COVID-19 Vaccines. These modules will provide information to healthcare professionals about COVID-19 vaccines manufactured by Moderna, Inc. and Pfizer Pharmaceuticals based on the recommendations of the Advisory Committee on Immunization Practices and guidance from the manufacturer. The target audience includes: Administrators, CHES certified health educators, Physicians, Epidemiologists, LPNs, LVNs, Medical assistants, medical students, NPs, nurse technicians, other health educators, Pharmacists, PAs, program managers RNs. Continuing Education (CE) credits are also available.
Preparing for the Potential Management of Anaphylaxis at COVID-19 Vaccination Sites – Locations administering COVID-19 vaccines should adhere to this CDC guidance for use of COVID-19 vaccines, including screening recipients for contraindications and precautions, having the necessary supplies available to manage anaphylaxis, implementing the recommended post-vaccination observation periods, and immediately treating suspected cases of anaphylaxis with intramuscular injection of epinephrine.